6092 — Enbio Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥5bn
- ¥10bn
- ¥8bn
- 36
- 64
- 25
- 33
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -60.3 | 834 | 488 | 1,099 | 1,233 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 652 | -62 | 102 | 98.5 | 127 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,473 | -247 | -660 | 873 | 229 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -372 | 952 | 297 | 2,413 | 1,989 |
Capital Expenditures | -631 | -359 | -1,731 | -1,165 | -1,165 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6.76 | 4,227 | -429 | -316 | -605 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -638 | 3,868 | -2,160 | -1,481 | -1,770 |
Financing Cash Flow Items | -1 | -167 | — | -86.4 | -22.2 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -154 | -4,062 | 929 | -535 | 241 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,165 | 769 | -966 | 356 | 457 |